HHS Moves to Expand Access to Unapproved Peptides Amid FDA Safety Concerns
HHS is expanding access to six unapproved peptides despite FDA safety concerns. The new policy raises questions about compounded drugs, patient protections and access to evidence-based treatments.
HHS Moves to Expand Access to Unapproved Peptides Amid FDA Safety Concerns Read More »






















